Back to Search Start Over

Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic

Authors :
Laure Diancourt
Etienne Simon-Loriere
Edward C. Holmes
Jan P. Buchmann
Gamou Fall
Matthias Vandenbogaert
Christiane Bouchier
Valérie Caro
Christian B. Matranga
N’Faly Magassouba
Oumar Faye
Sakoba Keita
Ousmane Faye
Jean-Michel Thiberge
Lamine Koivogui
Pardis C. Sabeti
Amadou A. Sall
Jean-Claude Manuguerra
Génétique fonctionnelle des Maladies infectieuses - Functional Genetics of Infectious Diseases
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)
Institut Pasteur de Dakar
Réseau International des Instituts Pasteur (RIIP)
Arbovirus et Virus de Fièvres Hémorragiques [Dakar, Sénégal]
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)
Institut National de Santé Publique [Conakry, Guinée] (INSP)
Ministère de la Santé [Conakry, Guinea]
Université Gamal Abdel Nasser de Conakry
Ministry of Health [Guinée]
Cellule d'Intervention Biologique d'Urgence - Laboratory for Urgent Response to Biological Threats (CIBU)
Institut Pasteur [Paris] (IP)
Environnement et Risques infectieux - Environment and Infectious Risks (ERI)
Génomique (Plate-Forme) - Genomics Platform
Génotypage des Pathogènes et Santé Publique (Plate-forme) (PF8)
The University of Sydney
Broad Institute [Cambridge]
Harvard University-Massachusetts Institute of Technology (MIT)
Harvard University
This study was supported by the Pasteur Ebola Task Force (PETF) and has also received funding from the French government’s Investissement d’Avenir programme, Laboratoire d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (grant number ANR-10-LABX-62-IBEID) and Institut Pasteur de Dakar. We are grateful to all members of the PETF for their support, and in particular F. Rey and K. Victoir. High-throughput sequencing was performed on the Genomics Platform of Institut Pasteur, member of ‘France Génomique’ consortium (ANR10-INBS-09-08).
We thank L. Ma for technical assistance and Institut Pasteur Clinical Research Department for their help with ethical approval procedures. E.C.H. is supported by an NHMRC Australia fellowship.
ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010)
ANR-10-INBS-0009,France-Génomique,Organisation et montée en puissance d'une Infrastructure Nationale de Génomique(2010)
Source :
Nature, Nature, 2015, 524 (7563), pp.102-104. ⟨10.1038/nature14612⟩
Publication Year :
2015
Publisher :
Springer Science and Business Media LLC, 2015.

Abstract

International audience; An epidemic of Ebola virus disease of unprecedented scale has been ongoing for more than a year in West Africa. As of 29 April 2015, there have been 26,277 reported total cases (of which 14,895 have been laboratory confirmed) resulting in 10,899 deaths. The source of the outbreak was traced to the prefecture of Guéckédou in the forested region of southeastern Guinea. The virus later spread to the capital, Conakry, and to the neighbouring countries of Sierra Leone, Liberia, Nigeria, Senegal and Mali. In March 2014, when the first cases were detected in Conakry, the Institut Pasteur of Dakar, Senegal, deployed a mobile laboratory in Donka hospital to provide diagnostic services to the greater Conakry urban area and other regions of Guinea. Through this process we sampled 85 Ebola viruses (EBOV) from patients infected from July to November 2014, and report their full genome sequences here. Phylogenetic analysis reveals the sustained transmission of three distinct viral lineages co-circulating in Guinea, including the urban setting of Conakry and its surroundings. One lineage is unique to Guinea and closely related to the earliest sampled viruses of the epidemic. A second lineage contains viruses probably reintroduced from neighbouring Sierra Leone on multiple occasions, while a third lineage later spread from Guinea to Mali. Each lineage is defined by multiple mutations, including non-synonymous changes in the virion protein 35 (VP35), glycoprotein (GP) and RNA-dependent RNA polymerase (L) proteins. The viral GP is characterized by a glycosylation site modification and mutations in the mucin-like domain that could modify the outer shape of the virion. These data illustrate the ongoing ability of EBOV to develop lineage-specific and potentially phenotypically important variation.

Details

ISSN :
14764687 and 00280836
Volume :
524
Database :
OpenAIRE
Journal :
Nature
Accession number :
edsair.doi.dedup.....9a1535fbb180990e56c23c8f659c80b3
Full Text :
https://doi.org/10.1038/nature14612